Fig. 3From: Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classificationROC curve of MET (a) and FLT (b) for differentiating IDH1-wildtype from IDH1-mutant tumours in all gliomas (n = 81). The area under the curve (AUC) of the FLT T/N ratio (AUC: 0.911, 95% CI 0.847–0.975) was significantly larger than that of the MET T/N ratio (AUC: 0.727, 95% CI 0.607–0.847)Back to article page